[1] |
Lammer J, Hein R, Roenneberg S, et al. Drug⁃induced linear IgA bullous dermatosis: a case report and review of the literature[J]. Acta Derm Venereol, 2019,99(6):508⁃515. doi: 10.2340/00015555⁃3154.
|
[2] |
Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults[J]. Br J Dermatol, 1982,107(3):301⁃316. doi: 10. 1111/j.1365⁃2133.1982.tb00360.x.
|
[3] |
荆可, 王媛, 李锁, 等. 表现为环状红斑水疱的自身免疫性表皮下水疱病25例回顾性分析[J]. 中华皮肤科杂志, 2023,56(9):832⁃838. doi: 10.35541/cjd.20230132.
|
[4] |
Cozzani E, Di Zenzo G, Gasparini G, et al. Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD⁃1 denoted as a major auto⁃antigen of the lamina lucida subtype[J]. Acta Derm Venereol, 2020,100(4):adv00070. doi: 10.2340/00015555⁃3415.
|
[5] |
Horiguchi Y, Ikoma A, Sakai R, et al. Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan[J]. J Dermatol, 2008,35(11):737⁃743. doi: 10.1111/j.1346⁃8138. 2008.00561.x.
|
[6] |
Metz BJ, Ruggeri SY, Hsu S, et al. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype[J]. Int J Dermatol, 2004,43(6):443⁃446. doi: 10.1111/j.1365⁃4632. 2004.02016.x.
|
[7] |
Kromminga A, Scheckenbach C, Georgi M, et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180[J]. J Autoimmun, 2000,15(3):293⁃300. doi: 10.1006/jaut.2000.0437.
|
[8] |
Zhou S, Ferguson DJ, Allen J, et al. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting[J]. Br J Dermatol, 1998,139(4):591⁃597. doi: 10.1046/j.1365⁃2133.1998.02453.x.
|
[9] |
Li X, Tsuchisaka A, Qian H, et al. Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins[J]. Eur J Dermatol, 2015,25(5):418⁃423. doi: 10.1684/ejd.2015.2555.
|
[10] |
Zenke Y, Nakano T, Eto H, et al. A case of vancomycin⁃associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin⁃332[J]. Br J Dermatol, 2014,170(4):965⁃969. doi: 10.1111/bjd.12720.
|
[11] |
Zillikens D, Herzele K, Georgi M, et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801[J]. J Invest Dermatol, 1999,113(6):947⁃953. doi: 10.1046/j.1523⁃1747.1999.00808.x.
|
[12] |
Utsunomiya N, Chino T, Oyama N, et al. Sublamina densa⁃type linear IgA bullous dermatosis with IgA autoantibodies specific for type Ⅶ collagen: a case report and clinicopathological review of 32 cases[J]. Dermatol Online J, 2017,23(11):13030/qt7 gj3j797[pii].
|
[13] |
Vodegel RM, de Jong MC, Pas HH, et al. IgA⁃mediated epidermolysis bullosa acquisita: two cases and review of the literature[J]. J Am Acad Dermatol, 2002,47(6):919⁃925. doi: 10.1067/mjd.2002.125079.
|
[14] |
Becker M, Schumacher N, Schmidt E, et al. Evaluation and comparison of clinical and ilaboratory characteristics of patients with IgA epidermolysis bullosa acquisita, linear IgA bullous dermatosis, and IgG epidermolysis bullosa acquisita[J]. JAMA Dermatol, 2021,157(8):917⁃923. doi: 10.1001/jamadermatol. 2021.0762.
|
[15] |
Ohata C, Ishii N, Koga H, et al. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence[J]. Br J Dermatol, 2017,177(1):152⁃157. doi: 10.1111/bjd.15232.
|
[16] |
Gottlieb J, Ingen⁃Housz⁃Oro S, Alexandre M, et al. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults[J]. Br J Dermatol, 2017,177(1):212⁃222. doi: 10.1111/bjd.15244.
|